Taming food-induced immune disorders Interviewee/Contributor Poul Sørensen Organisation Allero Therapeutics BV Drug discovery Immunotherapy Read more about Taming food-induced immune disorders
The US continues to lead in oncology approvals Interviewee/Contributor Bruno Pagliara Organisation MedNous Antibody Drug Conjugates ADCs Cancer (Oncology) Clinical trials Immunotherapy Policy & Regulation Read more about The US continues to lead in oncology approvals
Genmab looks ahead to next phase of growth Interviewee/Contributor Jan van de Winkel Organisation Genmab A/S Antibody Cancer (Oncology) Drug discovery Immunotherapy Strategy Read more about Genmab looks ahead to next phase of growth
Long-term strategies for immuno-oncology Interviewee/Contributor Bruno Pagliara Organisation On-kòs Pharma Consulting Cancer (Oncology) Immunotherapy Strategy Read more about Long-term strategies for immuno-oncology
Novel immunotherapy arises from collaboration Interviewee/Contributor Andrea van Elsas Organisation Aduro Biotech Inc Commentary Cancer (Oncology) Immunotherapy Read more about Novel immunotherapy arises from collaboration
Medigene on a new course Interviewee/Contributor Dolores Schendel Organisation Medigene AG Cancer (Oncology) Drug discovery Immunotherapy Read more about Medigene on a new course
Using the accelerator and brake to treat cancer Interviewee/Contributor Frédéric Triebel Organisation Prima BioMed Ltd Cancer (Oncology) Immunotherapy Read more about Using the accelerator and brake to treat cancer
How Pharma is targeting checkpoint inhibitors Interviewee/Contributor Bruno Pagliara Cancer (Oncology) Immunotherapy T-cells Read more about How Pharma is targeting checkpoint inhibitors
Immunotherapies start to transform cancer care Interviewee/Contributor Bruno Pagliara Organisation On-kòs Pharma Consulting Cancer (Oncology) Drug discovery Immunotherapy Read more about Immunotherapies start to transform cancer care
Bringing exhausted T cells back from the brink Interviewee/Contributor Stephen J Turner Organisation Biomedical Discovery Institute, Monash University Academic Research Cancer (Oncology) Immunotherapy T-cells Read more about Bringing exhausted T cells back from the brink